Who are Bacillus Calmette-Guerin: Strain TICE's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): BCG Solution, Bacille Calmette-Guérin (BCG), Bacillus Calmette-Guerin (BCG), Bacillus Calmette-Guérin (BCG), BCG for Injection, Bacillus Calmette-Guérin.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/bacillus-calmette-guerin-strain-tice.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Bacillus Calmette-Guerin: Strain TICE — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Bacillus Calmette-Guerin: Strain TICE (Bacillus Calmette-Guerin: Strain TICE) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine / Immunotherapy. Area: Oncology / Immunology.

phase 3 Live attenuated vaccine / Immunotherapy Pattern recognition receptors (TLR2, TLR4, NOD2); non-specific immune activation Oncology / Immunology Small molecule Live · refreshed every 30 min

Target snapshot

Bacillus Calmette-Guerin: Strain TICE (Bacillus Calmette-Guerin: Strain TICE) — Verity Pharmaceuticals Inc.. BCG TICE is a live attenuated mycobacterial vaccine that stimulates innate and adaptive immune responses to enhance anti-tumor immunity.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Bacillus Calmette-Guerin: Strain TICE TARGET	Bacillus Calmette-Guerin: Strain TICE	Verity Pharmaceuticals Inc.	phase 3	Live attenuated vaccine / Immunotherapy	Pattern recognition receptors (TLR2, TLR4, NOD2); non-specific immune activation
BCG Solution	BCG Solution	Alliance for Clinical Trials in Oncology	marketed	Live attenuated vaccine / Immunotherapy
Bacille Calmette-Guérin (BCG)	Bacille Calmette-Guérin (BCG)	TASK Applied Science	marketed	Live attenuated vaccine / Immunotherapy	Pattern recognition receptors (TLR2, TLR4, NOD2); non-specific immune activation
Bacillus Calmette-Guerin (BCG)	Bacillus Calmette-Guerin (BCG)	Massachusetts General Hospital	marketed	Live attenuated vaccine / Immunotherapy
Bacillus Calmette-Guérin (BCG)	Bacillus Calmette-Guérin (BCG)	Memorial Sloan Kettering Cancer Center	phase 3	Live attenuated vaccine / Immunotherapy	Pattern recognition receptors (TLR2, TLR4, NOD2); non-specific immune activation
BCG for Injection	BCG for Injection	Suzhou Suncadia Biopharmaceuticals Co., Ltd.	phase 3	Live attenuated vaccine / Immunotherapy	Toll-like receptors (TLR2, TLR4); non-specific immune activation
Bacillus Calmette-Guérin	Bacillus Calmette-Guérin	Massachusetts General Hospital	phase 3	Live attenuated vaccine / Immunotherapy

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine / Immunotherapy class)

Massachusetts General Hospital · 2 drugs in this class
Memorial Sloan Kettering Cancer Center · 1 drug in this class
Alliance for Clinical Trials in Oncology · 1 drug in this class
Suzhou Suncadia Biopharmaceuticals Co., Ltd. · 1 drug in this class
TASK Applied Science · 1 drug in this class
Verity Pharmaceuticals Inc. · 1 drug in this class
Nottingham University Hospitals NHS Trust · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Bacillus Calmette-Guerin: Strain TICE — Competitive Intelligence Brief. https://druglandscape.com/ci/bacillus-calmette-guerin-strain-tice. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab